Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAIC vs TACE in Large Unresectable HCC
NCT03048123Phase 2Completed
- Sponsor
- Sun Yat-sen University
- Start
- Oct 2015
- Primary completion
- Oct 2016
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, fluorouracil, folinic acid in hepatocellular carcinoma (HCC), sponsored by Sun Yat-sen University. Started Oct 2015; status: completed.
02
Drugs
oxaliplatinfluorouracilfolinic acid
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03048123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03048123.